The report on global
transcatheter embolization and occlusion devices market is an in depth analysis
of the segments and sub-segments in the transcatheter embolization and
occlusion devices market. The report provides analysis for the global as well
as regional markets over the period of 2015 to 2023. According to report the
global transcatheter embolization and occlusion devices market is expected to
grow at a CAGR of 9.5% over the forecast period of 2017 - 2023.
Figure 1: Global Transcatheter
Embolization and Occlusion Devices by Value 2015 – 2023
Segments Covered
The report on global
transcatheter embolization and occlusion devices market covers segments such as
product, application and end-user. The product segments include liquid
embolics, embolization particles, flow diverter devices, embolization coils and
accessories. On the basis of application, the global transcatheter embolization
and occlusion devices market is categorized into urology, oncology, neurology,
peripheral vascular disease and others. Furthermore, on the basis of end-user the
transcatheter embolization and occlusion devices market is segmented as clinics,
hospitals and ambulatory surgical centers.
Geographic Coverage
The report provides regional
analysis covering geographies such as North America, Europe, Asia-Pacific, and
Rest of the World. In this section the key trends and market size for each geography
is provided over the period of 2015 – 2023.
Figure 2: Global Transcatheter Embolization and Occlusion Devices
Market by Region, CAGR %, 2015-2023
The countries covered in the
North America region include the U.S., Canada, and Mexico; while Asia-Pacific
includes China, Japan, India, South Korea, Malaysia, and among others. The U.S.
drives the growth in the North America region as it is the largest market in
the region. The Asia-pacific region offers a substantial potential for the
market growth owing to rapid growth in markets such as India and China. The
APAC region is projected to experience a growth at a CAGR of x.x% over the
period of 2017 - 2023.
Companies Profiled:
The report provides profiles of
the companies in the global transcatheter embolization and occlusion devices market
such as, Abbott Laboratories, Boston Scientific Corporation, Stryker, Cook
Medical, Sirtex Medical Limited, Johnson & Johnson, Medtronic plc, DePuy
Synthes, Penumbra Inc., and Nordian.
Report Highlights:
The report provides deep insights
on demand forecasts, market trends and micro and macro indicators. In addition,
this report provides insights on the factors that are driving and restraining
the global transcatheter embolization and occlusion devices market. Moreover, IGR-Growth
Matrix analysis given in the report brings an insight on the investment areas
that existing or new market players can consider.
The report provides insights into
the market using analytical tools such as Porter’s five forces analysis and DRO
analysis of transcatheter embolization and occlusion devices market. Moreover,
the study highlights current market trends and provides forecast from 2017 to
2023. We also have highlighted future trends in the transcatheter embolization
and occlusion devices market that will impact the demand during the forecast
period. Moreover, the competitive analysis given in each regional market brings
an insight on the market share of the leading players. Additionally, the
analysis highlights rise and fall in the market shares of the key players in
the market.
This report will help
manufacturers, suppliers and distributors of the transcatheter embolization and
occlusion devices market to understand the present and future trends in this
market and formulate their strategies accordingly.
Please Choose One of them.